Raf inhibitor PLX4032, Purity ≥98%

Cat. No.: X23-10-ZQ954

Raf inhibitor PLX4032, Purity ≥98%

Synonym: Vemurafenib; 918504-65-1; PLX4032; Zelboraf; 1029872-54-5; PLX-4032; N-(3-(5-(4-Chlorophenyl)-1H-pyrrolo[2,3-b]pyridine-3-carbonyl)-2,4-difluorophenyl)propane-1-sulfonamide; Raf inhibitor

  • MDL: MFCD18074504
  • CAS Number: 918504-65-1
  • Compound CID: 42611257
Product Size
10 mg; 25 mg; 50 mg; 100 mg; 200 mg
Price
Datasheet
MSDS
Properties
Description
PLX4032, soluble in DMSO and insoluble in ethanol and water, blocks a MAPK/ERK signaling pathway. It targets ACK1, B-Raf (V600E), B-Raf, and BLK.
Molecular Weight
489.9
Molecular Formula
C23H18ClF2N3O3S
Targets
ACK1: 19 nM; B-Raf (V600E): 31 nM; B-Raf: 100 nM; BLK: 547 nM
Form
Lyophilized powder
Purity
≥98%
Solubility
DMSO: 83 mg/mL (169.41 mM); Water: Insoluble; Ethanol: Insoluble
Identity
Confirmed by NMR/HPLC/MS.
Stability
The product is stable for three years when stored at the recommended temperature in lyophilized powder.
Applications
PLX4032 can be utilized to study BRAF V600E and associated melanoma treatments by inhibiting mutant BRAF.
Storage
Store at -20ºC.
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.